Expert shares advice and tools for Houston companies returning to their office space

Guest column

More and more Houston companies are having employees return to the office, but business leaders should take advantage of new tools and best practices. Getty Images

As states begin to relax their stay-at-home orders and communities plan for the reopening of local economies, many may be returning to work and engaging in more regular social activity. While the return to some semblance of normalcy may come as a relief, questions about one's own health or the health of family members may remain.

Upon returning to work, people should continue to be smart and cautious while interacting with others. Following CDC guidelines and maintaining social distancing, practicing good hand hygiene and frequently sanitizing common areas or high-contact items, including doorknobs, hand railings and communal phones and printers, can be good preventive measures to help mitigate COVID-19 health risks.

Business associations, health systems, and governments are crafting guidelines to help mitigate risks associated with reopening communities, but additional resources may be available to help individuals navigate their own physical and mental health during this transition period.

Many may continue to have questions related to potential COVID-19 symptoms. To help, UnitedHealthcare provides an online COVID-19 symptom self-checker to help people gauge their symptoms and consider what may be the next steps for care. The symptom self-checker is at no additional cost for people to access, and users of the self-checker tool will be asked to answer a series of questions to generate feedback on care options to consider, which then assigns assessment levels ranging from self-isolation to emergency care, depending on the severity and urgency of the symptoms recorded. A testing site locator feature provides updated information on nearby COVID-19 testing sites if recommended by a physician.

Some people may still need to see a doctor but may worry about the potential risk of exposure (or the risk of exposing others) with in-person visits to a physician's office or urgent care center. As an alternative starting point for care, some people may continue to consider telehealth, which enables people to connect 24/7 with a health care provider via a smart phone, tablet or desktop computer. Telehealth may be especially helpful as an initial option for medical advice related to COVID-19, and to help evaluate other possible health issues, such as allergies, pink eye or the flu.

Employers also have a tool available for their employees. ProtectWell, a new smartphone app just launched by Microsoft and UnitedHealth Group, screens employees for COVID-19. Employees found to be at-risk for COVID-19 are directed to get a test and the app notifies employers of the results. The ProtectWell app is offered to all employers in the United States at no charge.

Access to mental health resources may also continue to be an important tool for people to have as they head back to work. Being at home and perhaps feeling isolated over the last few months may have had an impact on one's mental health, and the loneliness people may be experiencing, as well as possible stress or anxiety brought on by the pandemic, should be considered alongside physical health.

Virtual mental health resources are available for those experiencing increased stress and anxiety. A free emotional support line (866-342-6892) is available 24/7 to the public courtesy of Optum, which is part of UnitedHealth Group. Staffed by mental health professionals, individuals may receive help without taking any unnecessary trips.

Available at no additional cost, mental health and wellness apps, like Sanvello, may also be great resources for coping with the ongoing stress and anxiety. Equipped with self-care tools, peer support groups, coaching and therapy, Sanvello offers a number of avenues to receive the help and support one may need as they return to work.

For people who used mental health services before COVID-19, some care providers offer long-distance counseling and other resources, enabling for continued care from the comfort of home. Check with your providers regarding options on what may work best for you.

Taking care of physical and mental health needs may be imperative in the coming weeks and months as communities strive to reopen and individuals resume more familiar living routines. Using online and telehealth services may play a role in facilitating a smoother and healthier transition.

------

Dr. Sarah-Anne Schumann is the chief medical officer for UnitedHealthcare of Oklahoma and North Texas.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston hospital names leading cancer scientist as new academic head

new hire

Houston Methodist Academic Institute has named cancer clinician and scientist Dr. Jenny Chang as its new executive vice president, president, CEO, and chief academic officer.

Chang was selected following a national search and will succeed Dr. H. Dirk Sostman, who will retire in February after 20 years of leadership. Chang is the director of the Houston Methodist Dr. Mary and Ron Neal Cancer Center and the Emily Herrmann Presidential Distinguished Chair in Cancer Research. She has been with Houston Methodist for 15 years.

Over the last five years, Chang has served as the institute’s chief clinical science officer and is credited with strengthening cancer clinical trials. Her work has focused on therapy-resistant cancer stem cells and their treatment, particularly relating to breast cancer.

Her work has generated more than $35 million in funding for Houston Methodist from organizations like the National Institutes of Health and the National Cancer Institute, according to the health care system. In 2021, Dr. Mary Neal and her husband Ron Neal, whom the cancer center is now named after, donated $25 million to support her and her team’s research on advanced cancer therapy.

In her new role, Chang will work to expand clinical and translational research and education across Houston Methodist in digital health, robotics and bioengineered therapeutics.

“Dr. Chang’s dedication to Houston Methodist is unparalleled,” Dr. Marc L. Boom, Houston Methodist president and CEO, said in a news release. “She is committed to our mission and to helping our patients, and her clinical expertise, research innovation and health care leadership make her the ideal choice for leading our academic mission into an exciting new chapter.”

Chang is a member of the American Association of Cancer Research (AACR) Stand Up to Cancer Scientific Advisory Council. She earned her medical degree from Cambridge University in England and completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research. She earned her research doctorate from the University of London.

She is also a professor at Weill Cornell Medical School, which is affiliated with the Houston Methodist Academic Institute.

Texas A&M awarded $1.3M federal grant to develop clean energy tech from electronic waste

seeing green

Texas A&M University in College Station has received a nearly $1.3 million federal grant for development of clean energy technology.

The university will use the $1,280,553 grant from the U.S. Department of Energy to develop a cost-effective, sustainable method for extracting rare earth elements from electronic waste.

Rare earth elements (REEs) are a set of 17 metallic elements.

“REEs are essential components of more than 200 products, especially high-tech consumer products, such as cellular telephones, computer hard drives, electric and hybrid vehicles, and flat-screen monitors and televisions,” according to the Eos news website.

REEs also are found in defense equipment and technology such as electronic displays, guidance systems, lasers, and radar and sonar systems, says Eos.

The grant awarded to Texas A&M was among $17 million in DOE grants given to 14 projects that seek to accelerate innovation in the critical materials sector. The federal Energy Act of 2020 defines a critical material — such as aluminum, cobalt, copper, lithium, magnesium, nickel, and platinum — as a substance that faces a high risk of supply chain disruption and “serves an essential function” in the energy sector.

“DOE is helping reduce the nation’s dependence on foreign supply chains through innovative solutions that will tap domestic sources of the critical materials needed for next-generation technologies,” says U.S. Energy Secretary Jennifer Granholm. “These investments — part of our industrial strategy — will keep America’s growing manufacturing industry competitive while delivering economic benefits to communities nationwide.”

------

This article originally appeared on EnergyCapital.

Biosciences startup becomes Texas' first decacorn after latest funding

A Dallas-based biosciences startup whose backers include millionaire investors from Austin and Dallas has reached decacorn status — a valuation of at least $10 billion — after hauling in a series C funding round of $200 million, the company announced this month. Colossal Biosciences is reportedly the first Texas startup to rise to the decacorn level.

Colossal, which specializes in genetic engineering technology designed to bring back or protect various species, received the $200 million from TWG Global, an investment conglomerate led by billionaire investors Mark Walter and Thomas Tull. Walter is part owner of Major League Baseball’s Los Angeles Dodgers, and Tull is part owner of the NFL’s Pittsburgh Steelers.

Among the projects Colossal is tackling is the resurrection of three extinct animals — the dodo bird, Tasmanian tiger and woolly mammoth — through the use of DNA and genomics.

The latest round of funding values Colossal at $10.2 billion. Since launching in 2021, the startup has raised $435 million in venture capital.

In addition to Walter and Tull, Colossal’s investors include prominent video game developer Richard Garriott of Austin and private equity veteran Victor Vescov of Dallas. The two millionaires are known for their exploits as undersea explorers and tourist astronauts.

Aside from Colossal’s ties to Dallas and Austin, the startup has a Houston connection.

The company teamed up with Baylor College of Medicine researcher Paul Ling to develop a vaccine for elephant endotheliotropic herpesvirus (EEHV), the deadliest disease among young elephants. In partnership with the Houston Zoo, Ling’s lab at the Baylor College of Medicine has set up a research program that focuses on diagnosing and treating EEHV, and on coming up with a vaccine to protect elephants against the disease. Ling and the BCMe are members of the North American EEHV Advisory Group.

Colossal operates research labs Dallas, Boston and Melbourne, Australia.

“Colossal is the leading company working at the intersection of AI, computational biology, and genetic engineering for both de-extinction and species preservation,” Walter, CEO of TWG Globa, said in a news release. “Colossal has assembled a world-class team that has already driven, in a short period of time, significant technology innovations and impact in advancing conservation, which is a core value of TWG Global.”

Well-known genetics researcher George Church, co-founder of Colossal, calls the startup “a revolutionary genetics company making science fiction into science fact.”

“We are creating the technology to build de-extinction science and scale conservation biology,” he added, “particularly for endangered and at-risk species.”

View All Listings